Splash Clinical, a patient recruitment solutions provider, and Cambridge Cognition, a digital health company specializing in brain health assessments, have announced a partnership aimed at improving recruitment for clinical trials focused on central nervous system (CNS) disorders. The collaboration seeks to integrate Cambridge Cognition's CANTAB (Cambridge Neuropsychological Test Automated Battery) into Splash Clinical's recruitment platform to streamline the pre-screening process for potential trial participants.
The integration of CANTAB into Splash Clinical's platform is designed to enhance patient qualification early in the recruitment process. CANTAB, a cognitive assessment tool, can be completed online in approximately 5-10 minutes, providing researchers with crucial pre-screening data before in-person visits. This is expected to reduce screening failures and improve the quality of patients entering clinical trials.
"We're thrilled to partner with Cambridge Cognition," said Matt Teuteberg, Founder and CEO of Splash Clinical. "By integrating their assessment tools into our platform, we will increase our efficiency in finding the right patients for clinical trials. This partnership will save time and resources for our clients and ultimately make treatments available for patients faster."
Liam Kaufman, VP of Clinical Sciences at Cambridge Cognition, added, "Partnering with Splash just made sense for us. They've got a great recruitment platform and a solid track record in recruitment. Our tools complement their process perfectly. Our goal is to make it easier for researchers to find the right participants for their CNS trials. It's a win-win for everyone involved."
A pilot study conducted last year demonstrated the potential benefits of this integration. Cambridge Cognition's software aided in identifying patients with early Alzheimer's symptoms, a population often difficult to recruit. The results indicated a significant reduction in screen failures and an increase in the quality of participants enrolled in the trial. Based on these findings, Splash Clinical and Cambridge Cognition are expanding their collaboration to encompass a wider range of CNS indications.
Splash Clinical, founded in 2011 and based in Wauwatosa, WI, specializes in patient recruitment solutions, utilizing digital media, mobile technologies, social media, and real-time analytics to expedite enrollment for clinical studies. Cambridge Cognition develops digital health products for understanding, detecting, and treating conditions affecting brain health. Their software products assess cognitive health to improve clinical trial outcomes and patient stratification.
